BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND HOXA9, HOX1, 3205, ENSG00000078399, HOX1G, P31269
37 results:

  • 1. Heritable defects in telomere and mitotic function selectively predispose to sarcomas.
    Ballinger ML; Pattnaik S; Mundra PA; Zaheed M; Rath E; Priestley P; Baber J; Ray-Coquard I; Isambert N; Causeret S; van der Graaf WTA; Puri A; Duffaud F; Le Cesne A; Seddon B; Chandrasekar C; Schiffman JD; Brohl AS; James PA; Kurtz JE; Penel N; Myklebost O; Meza-Zepeda LA; Pickett H; Kansara M; Waddell N; Kondrashova O; Pearson JV; Barbour AP; Li S; Nguyen TL; Fatkin D; Graham RM; Giannoulatou E; Green MJ; Kaplan W; Ravishankar S; Copty J; Powell JE; Cuppen E; van Eijk K; Veldink J; Ahn JH; Kim JE; Randall RL; Tucker K; Judson I; Sarin R; Ludwig T; Genin E; Deleuze JF; ; Haber M; Marshall G; Cairns MJ; Blay JY; ; Thomas DM; Tattersall M; Neuhaus S; Lewis C; Tucker K; Carey-Smith R; Wood D; Porceddu S; Dickinson I; Thorne H; James P; Ray-Coquard I; Blay JY; Cassier P; Le Cesne A; Duffaud F; Penel N; Isambert N; Kurtz JE; Puri A; Sarin R; Ahn JH; Kim JE; Ward I; Judson I; van der Graaf W; Seddon B; Chandrasekar C; Rickar R; Hennig I; Schiffman J; Randall RL; Silvestri A; Zaratzian A; Tayao M; Walwyn K; Niedermayr E; Mang D; Clark R; Thorpe T; MacDonald J; Riddell K; Mar J; Fennelly V; Wicht A; Zielony B; Galligan E; Glavich G; Stoeckert J; Williams L; Djandjgava L; Buettner I; Osinki C; Stephens S; Rogasik M; Bouclier L; Girodet M; Charreton A; Fayet Y; Crasto S; Sandupatla B; Yoon Y; Je N; Thompson L; Fowler T; Johnson B; Petrikova G; Hambridge T; Hutchins A; Bottero D; Scanlon D; Stokes-Denson J; Génin E; Campion D; Dartigues JF; Deleuze JF; Lambert JC; Redon R; Ludwig T; Grenier-Boley B; Letort S; Lindenbaum P; Meyer V; Quenez O; Dina C; Bellenguez C; Le Clézio CC; Giemza J; Chatel S; Férec C; Le Marec H; Letenneur L; Nicolas G; Rouault K
    Science; 2023 Jan; 379(6629):253-260. PubMed ID: 36656928
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Propofol inhibits glioma progression by regulating circMAPK4/miR-622/hoxa9 axis.
    Xiao G; Yu L; Tan W; Yang H; Li W; Xia R; Li Y
    Metab Brain Dis; 2023 Jan; 38(1):233-244. PubMed ID: 36326978
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prokineticins as a Prognostic Biomarker for Low-Grade Gliomas: A Study Based on The Cancer Genome Atlas Data.
    Zhong J; Xiang D; Ma X
    Biomed Res Int; 2022; 2022():2309339. PubMed ID: 35845958
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Next-generation sequencing identifies HOXA6 as a novel oncogenic gene in low grade glioma.
    Xiulin J; Wang C; Guo J; Wang C; Pan C; Nie Z
    Aging (Albany NY); 2022 Mar; 14(6):2819-2854. PubMed ID: 35349479
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. In Search of TGCT Biomarkers: A Comprehensive
    Raos D; Krasic J; Masic S; Abramovic I; Coric M; Kruslin B; Katusic Bojanac A; Bulic-Jakus F; Jezek D; Ulamec M; Sincic N
    Dis Markers; 2020; 2020():8841880. PubMed ID: 33224314
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Hsa_circ_0043278 functions as competitive endogenous RNA to enhance glioblastoma multiforme progression by sponging miR-638.
    Wu Z; Zheng M; Zhang Y; Xie M; Tian S; Ding T; Li L; Guan Q
    Aging (Albany NY); 2020 Nov; 12(21):21114-21128. PubMed ID: 33154193
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A novel molecular link between hoxa9 and WNT6 in glioblastoma identifies a subgroup of patients with particular poor prognosis.
    Gonçalves CS; Xavier-Magalhães A; Martins EP; Pinto AA; Pires MM; Pinheiro C; Reis RM; Sousa N; Costa BM
    Mol Oncol; 2020 Jun; 14(6):1224-1241. PubMed ID: 31923345
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. miR-647 inhibits glioma cell proliferation, colony formation and invasion by regulating hoxa9.
    Qin K; Tian G; Chen G; Zhou D; Tang K
    J Gene Med; 2020 Mar; 22(3):e3153. PubMed ID: 31881106
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. miR-652 Promotes Proliferation and Migration of Uveal Melanoma cells by Targeting hoxa9.
    Xia Z; Yang C; Yang X; Wu S; Feng Z; Qu L; Chen X; Liu L; Ma Y
    Med Sci Monit; 2019 Nov; 25():8722-8732. PubMed ID: 31740654
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Poly Combs the Immune System: PRC2 Loss in Malignant Peripheral Nerve Sheath tumors Can Dampen Immune Responses.
    Natarajan SK; Venneti S
    Cancer Res; 2019 Jul; 79(13):3172-3173. PubMed ID: 31262833
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. MiR-638 serves as a tumor suppressor by targeting hoxa9 in glioma.
    Zheng DH; Wang X; Lu LN; Chen DL; Chen JM; Lin FM; Xu XB
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7798-7806. PubMed ID: 30536324
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. DNA methylation profiling as a tool for testicular germ cell tumors subtyping.
    Costa AL; Moreira-Barbosa C; Lobo J; Vilela-Salgueiro B; Cantante M; Guimarães R; Lopes P; Braga I; Oliveira J; Antunes L; Henrique R; Jerónimo C
    Epigenomics; 2018 Dec; 10(12):1511-1523. PubMed ID: 30418048
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Is NF2 a Key Player of the Differentially Expressed Gene Between Spinal Cord Ependymoma and Intracranial Ependymoma?
    Kim KT; Lee CH; Chung CK; Kim JH
    World Neurosurg; 2018 Oct; 118():e906-e917. PubMed ID: 30031196
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. In vitro characterization of CD133
    Nair RM; Balla MM; Khan I; Kalathur RKR; Kondaiah P; Vemuganti GK
    BMC Cancer; 2017 Nov; 17(1):779. PubMed ID: 29162051
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma.
    Wouters J; Vizoso M; Martinez-Cardus A; Carmona FJ; Govaere O; Laguna T; Joseph J; Dynoodt P; Aura C; Foth M; Cloots R; van den Hurk K; Balint B; Murphy IG; McDermott EW; Sheahan K; Jirström K; Nodin B; Mallya-Udupi G; van den Oord JJ; Gallagher WM; Esteller M
    BMC Med; 2017 Jun; 15(1):101. PubMed ID: 28578692
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. HOXA7, hoxa9, and HOXA10 are differentially expressed in clival and sacral chordomas.
    Jäger D; Barth TFE; Brüderlein S; Scheuerle A; Rinner B; von Witzleben A; Lechel A; Meyer P; Mayer-Steinacker R; Baer AV; Schultheiss M; Wirtz CR; Möller P; Mellert K
    Sci Rep; 2017 May; 7(1):2032. PubMed ID: 28515451
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Roles of miR-196a on gene regulation of neuroendocrine tumor cells.
    Li SC; Shi H; Khan M; Caplin M; Meyer T; Öberg K; Giandomenico V
    Mol Cell Endocrinol; 2015 Sep; 412():131-9. PubMed ID: 26052033
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The Molecular Feature of HOX Gene Family in the Intramedullary Spinal tumors.
    Gu S; Gu W; Shou J; Xiong J; Liu X; Sun B; Yang D; Xie R
    Spine (Phila Pa 1976); 2017 Mar; 42(5):291-297. PubMed ID: 25785959
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A transcriptomic signature mediated by hoxa9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomide.
    Pojo M; Gonçalves CS; Xavier-Magalhães A; Oliveira AI; Gonçalves T; Correia S; Rodrigues AJ; Costa S; Pinto L; Pinto AA; Lopes JM; Reis RM; Rocha M; Sousa N; Costa BM
    Oncotarget; 2015 Apr; 6(10):7657-74. PubMed ID: 25762636
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Stronger prognostic power of the CpG island methylator phenotype than methylation of individual genes in neuroblastomas.
    Asada K; Watanabe N; Nakamura Y; Ohira M; Westermann F; Schwab M; Nakagawara A; Ushijima T
    Jpn J Clin Oncol; 2013 Jun; 43(6):641-5. PubMed ID: 23619990
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.